- Home
- HGBL vs IGMS Comparison
HGBL vs IGMS Comparison
Compare HGBL & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HGBL
- IGMS
- Stock Information
- Founded
- HGBL 1937
- IGMS 1993
- Country
- HGBL United States
- IGMS United States
- Employees
- HGBL N/A
- IGMS N/A
- Industry
- HGBL Business Services
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- HGBL Consumer Discretionary
- IGMS Health Care
- Exchange
- HGBL Nasdaq
- IGMS Nasdaq
- Market Cap
- HGBL 72.3M
- IGMS 82.1M
- IPO Year
- HGBL N/A
- IGMS 2019
- Fundamental
- Price
- HGBL $2.05
- IGMS $1.13
- Analyst Decision
- HGBL Strong Buy
- IGMS Hold
- Analyst Count
- HGBL 1
- IGMS 8
- Target Price
- HGBL $4.00
- IGMS $6.14
- AVG Volume (30 Days)
- HGBL 61.7K
- IGMS 152.8K
- Earning Date
- HGBL 05-08-2025
- IGMS 05-20-2025
- Dividend Yield
- HGBL N/A
- IGMS N/A
- EPS Growth
- HGBL N/A
- IGMS N/A
- EPS
- HGBL 0.14
- IGMS N/A
- Revenue
- HGBL $45,361,000.00
- IGMS $2,679,000.00
- Revenue This Year
- HGBL $10.82
- IGMS $121.76
- Revenue Next Year
- HGBL $15.17
- IGMS $46.83
- P/E Ratio
- HGBL $14.79
- IGMS N/A
- Revenue Growth
- HGBL N/A
- IGMS 25.77
- 52 Week Low
- HGBL $1.52
- IGMS $0.92
- 52 Week High
- HGBL $2.74
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- HGBL 51.34
- IGMS 39.53
- Support Level
- HGBL $1.96
- IGMS $1.11
- Resistance Level
- HGBL $2.07
- IGMS $1.22
- Average True Range (ATR)
- HGBL 0.08
- IGMS 0.11
- MACD
- HGBL 0.01
- IGMS -0.02
- Stochastic Oscillator
- HGBL 50.00
- IGMS 5.56
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.